Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Truly Labs AB

Anna Törner: ”Mitt kvantifierade liv”

”Uttrycket om att man inte ser skogen för alla träd känns nyaktuellt i kontexten wearbales. Det är lätt att fångas av tanken att ju mer vi mäter, desto mer vet ...

Here are the pharmaceutical companies best prepared for AI

How well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

One last chance to register for the premier metrology event in 2024

ZEISS QUALITY INNOVATION SUMMIT.

Enighet i EU om åtta års dataexklusivitet för nya läkemedel

Nya läkemedel ska omfattas av åtta års dataexklusivitet, enligt det förslag till ny läkemedelslagstiftning som EU-länderna efter långdragna förhandlingar nu enats om.

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Marie Gårdmark: “What to expect from Trump’s second term?”

One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...

Studie: Omtalat diabetesläkemedel kan ha effekt mot leversjukdom

Efter framgångarna inom diabetes och viktminskning – nu pekas ytterligare ett potentiellt terapiområde ut för Ozempic och andra GLP1-analoger. I en ny studie ko...

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

Several departures at the top at Nykode

Members of both the management and the board are leaving the Norwegian biotech company Nykode.

Christina Lloyd: ”Vi måste koppla kvinnohälsa till ledarskap”

Nätverket Vilda, som verkar för att stärka kvinnligt ledarskap och främja jämställdhet inom life science, har på kort tid vuxit i medlemsantal. Nu är siktet ins...

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

New moves around Nykode's management – withdrawal of resignations

Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...

Pfizer värvar FDA-topp – kritiseras hårt

Läkemedelsjätten Pfizers rekrytering av Patrizia Cavazzoni, tills helt nyligen toppchef vid FDA, som ny medicinsk chef får frän kritik från flera håll.

Investigations against AstraZeneca: ”Chinese interests may be behind them”

Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.

TFS Trial Form Support AB

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...